Survival in population-based pancreatic cancer patients: San Francisco Bay Area, 1995-1999

American Journal of Epidemiology

Volumn 174, Issue 12, 2011, Pages 1373-1381

  Gong, Zhihong ^a   Holly, Elizabeth A ^a   Bracci, Paige M ^a  

^a NONE

Author keywords

Cohort studies; Pancreatic neoplasms; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

COHORT ANALYSIS; HEALTH IMPACT; MEDICAL GEOGRAPHY; MULTIVARIATE ANALYSIS; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS; SURVIVAL; TUMOR;

ADULT; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PACIFIC ISLANDER; PANCREAS CANCER; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SAN FRANCISCO; SEX FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

ASIA; CALIFORNIA; PACIFIC ISLANDS; PACIFIC OCEAN; SAN FRANCISCO BAY; UNITED STATES;

EID: 83755225714     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr267     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
3. Tsiotos GG, Farnell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving? World J Surg. 1999;23(9):913-919. (Pubitemid 29398473)
4. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198(5):722-731. (Pubitemid 38542900)
5. Mambrini A, Bassi C, Pacetti P, et al. Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy. Pancreas. 2008;36(1):56-60.
6. Tani M, Kawai M, Terasawa H, et al. Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer. J Hepatobiliary Pancreat Surg. 2007;14(6):545-550. (Pubitemid 350201464)
7. Ghaneh P, Smith R, Tudor-Smith C, et al. Neoadjuvant and adjuvant strategies for pancreatic cancer. Eur J Surg Oncol. 2008;34(3):297-305. (Pubitemid 351312868)
8. Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998; 227(6):821-831. (Pubitemid 29119529)
9. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(4):836-847.
10. Lau MK, Davila JA, Shaib YH. Incidence and survival of pancreatic head and body and tail cancers: A populationbased study in the United States. Pancreas. 2010;39(4): 458-462.
11. Cress RD, Yin D, Clarke L, et al. Survival among patients with adenocarcinoma of the pancreas: A population-based study (United States). Cancer Causes Control. 2006;17(4): 403-409.
12. Eloubeidi MA, Desmond RA, Wilcox CM, et al. Prognostic factors for survival in pancreatic cancer: A population-based study. Am J Surg. 2006;192(3):322-329. (Pubitemid 44226455)
13. Zell JA, Rhee JM, Ziogas A, et al. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16(3): 546-552. (Pubitemid 46548659)
14. Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14(4):1320-1326. (Pubitemid 46536816)
15. Artinyan A, Soriano PA, Prendergast C, et al. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford). 2008;10(5):371-376.
16. Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol. 2003;158(5):432-441. (Pubitemid 37022841)
17. Holly EA, Chaliha I, Bracci PM, et al. Signs and symptoms of pancreatic cancer: A population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol. 2004; 2(6):510-517. (Pubitemid 38698368)
18. Cox DR. Regression models with life tables (with discussion). J R Stat Soc (B). 1972;34(2):187-220.
19. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1-7. (Pubitemid 29307735)
20. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006;24(1):87-94. (Pubitemid 43894008)
21. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: A populationbased, linked database analysis of 396 patients. Ann Surg. 2003;237(1):74-85. (Pubitemid 36622320)
22. Gudjonsson B. Survival statistics gone awry: pancreatic cancer, a case in point. J Clin Gastroenterol. 2002;35(2):180-184. (Pubitemid 34815858)
23. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, singleinstitution experience. Ann Surg. 1997;225(5):621-633; discussion 633-636.
24. Shaib Y, Davila J, Naumann C, et al. The impact of curative intent surgery on the survival of pancreatic cancer patients: A U.S. population-based study. Am J Gastroenterol. 2007; 102(7):1377-1382. (Pubitemid 46976285)
25. Krzyzanowska MK,Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: populationbased practices and effectiveness. J Clin Oncol. 2003;21(18): 3409-3414. (Pubitemid 46594073)
26. Jefford M, Thursfield V, Torn-Broers Y, et al. Use of chemotherapy and radiotherapy in patients with pancreatic cancer in Victoria (2002-2003): A retrospective cohort study. Med J Aust. 2010;192(6):323-327.
27. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247(3):456-462.
28. Westgaard A, Larønningen S, Mellem C, et al. Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer. 2009;45(16):2850-2859.